These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6669143)

  • 61. Symposium on surgical treatment of morbid obesity. Proceedings of a consensus conference sponsored by the National Institute of Arthritis, Metabolism, and Digestive Diseases of the National Institutes of Health; held in December 1978 at Bethesda, Maryland.
    Am J Clin Nutr; 1980 Feb; 33(2 Suppl):353-530. PubMed ID: 6101932
    [No Abstract]   [Full Text] [Related]  

  • 62. Attempt to establish a correlation between the alkylation ability and antitumor activity of some bis(2-chloroethyl)aminoethyl esters of carboxylic acids.
    Manolov I; Golovinsky EV
    Pharmazie; 1988 Mar; 43(3):218-9. PubMed ID: 3380873
    [No Abstract]   [Full Text] [Related]  

  • 63. National Institutes of Health Consensus Development Conference on Oral Complications of Cancer Therapies: Diagnosis, Prevention, and Treatment. Bethesda, Maryland, April 17-19, 1989.
    NCI Monogr; 1990; (9):1-184. PubMed ID: 2188147
    [No Abstract]   [Full Text] [Related]  

  • 64. The National Institutes of Health Consensus Development Conference: Adjuvant Therapy for Breast Cancer. Bethesda, Maryland, USA. November 1-3, 2000. Proceedings.
    J Natl Cancer Inst Monogr; 2001; (30):1-152. PubMed ID: 12083020
    [No Abstract]   [Full Text] [Related]  

  • 65. Anti-inflammatory drugs.
    Van Arman CG
    Clin Pharmacol Ther; 1974 Nov; 16(5 Part 2):900-4. PubMed ID: 4417436
    [No Abstract]   [Full Text] [Related]  

  • 66. [Current pharmacotherapy of neoplastic diseases. II].
    Witkowska M
    Wiad Lek; 1969 Jul; 22(14):1307-13. PubMed ID: 5344011
    [No Abstract]   [Full Text] [Related]  

  • 67. [The dependence of the cytokinetic effects of alkylating antitumor preparations on the phase of the hepatocyte cell cycle in regenerating liver].
    Uryvaeva IV; Sokolov AS; Kalistratov SG; Delone GV
    Izv Akad Nauk SSSR Biol; 1991; (6):816-28. PubMed ID: 1809781
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pyrimidines. V. Some higher 5-substituted 2,4,6-trichloropyrimidines.
    Gershon H; Parmegiani R; D'Ascoli R
    J Med Chem; 1967 Jan; 10(1):113-5. PubMed ID: 6031688
    [No Abstract]   [Full Text] [Related]  

  • 69. METHYLATED PURINES AND PYRIMIDINES. I. SYNTHESES OF 8-HYDROXY-7-METHYLGUANINE AND METHYLATION OF A 5-(BENZYLIDENEAMINO) PYRIMIDINE.
    BOROWITZ IJ; BLOOM SM; ROTHSCHILD J; SPRINSON DB
    Biochemistry; 1965 Apr; 4():650-5. PubMed ID: 14323566
    [No Abstract]   [Full Text] [Related]  

  • 70. Workshop on Fat and Cancer. Sponsored by the Diet, Nutrition and Cancer Program of the National Cancer Institute. Held at the National Institutes of Health, Bethesda, Maryland, December 10 - 12, 1979.
    Cancer Res; 1981 Sep; 41(9 Pt 2):3677-826. PubMed ID: 7260923
    [No Abstract]   [Full Text] [Related]  

  • 71. Anticancer activity of (1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-pyrimidines and -purines against the MCF-7 cell line: Preliminary cDNA microarray studies.
    Díaz-Gavilán M; Gómez-Vidal JA; Rodríguez-Serrano F; Marchal JA; Caba O; Aránega A; Gallo MA; Espinosa A; Campos JM
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1457-60. PubMed ID: 18194866
    [TBL] [Abstract][Full Text] [Related]  

  • 72. METHYLATED PURINES AND PYRIMIDINES. II. SYNTHESIS AND PROPERTIES OF 2,6-DIAMINO-5-(METHYLAMINO)-4-PYRIMIDINOL.
    SPRECHER M; SPRINSON DB
    Biochemistry; 1965 Apr; 4():655-61. PubMed ID: 14323567
    [No Abstract]   [Full Text] [Related]  

  • 73. Synthesis, chemistry, and preliminary pharmacology of arsenical nitrogen mustards and structurally related nonalkylating arsenicals.
    Bardos TJ; Datta-Gupta N; Hebborn P
    J Med Chem; 1966 Mar; 9(2):221-7. PubMed ID: 5911802
    [No Abstract]   [Full Text] [Related]  

  • 74. Cancer chemotherapy with purine and pyrimidine analogues.
    Heidelberger C
    Annu Rev Pharmacol; 1967; 7():101-24. PubMed ID: 5337075
    [No Abstract]   [Full Text] [Related]  

  • 75. The development of hypoxic tumor cell cytotoxic agents.
    Kirkpatrick DL
    Pharmacol Ther; 1989; 40(3):383-99. PubMed ID: 2646652
    [No Abstract]   [Full Text] [Related]  

  • 76. Studies on 2-(alpha-hydroxybenzyl)benzimidazole (HBB) analogs. I. Synthesis of 8-(alpha-hydroxybenzyl)purines, the diaza analogs of HBB.
    Haggerty WJ; Springer RH; Cheng CC
    J Med Chem; 1965 Nov; 8(6):797-802. PubMed ID: 4287199
    [No Abstract]   [Full Text] [Related]  

  • 77. [Immunosuppressive agents in treatment of inflammation of the connective tissue].
    Schiavetti L; Baccarini V; Marroni P; Porzio F; Ravetta M
    Minerva Med; 1973 Aug; 64(57):2983-6. PubMed ID: 4742636
    [No Abstract]   [Full Text] [Related]  

  • 78. [Specific histotropism of antineoplastic agents].
    Berti T
    Clin Ter; 1970 Nov; 55(4):293-303. PubMed ID: 4930868
    [No Abstract]   [Full Text] [Related]  

  • 79. [Antineoplastic drugs developed in the USSR].
    Safonova TS; Cernov VA
    Cesk Farm; 1974 Dec; 23(10):416-20. PubMed ID: 4455404
    [No Abstract]   [Full Text] [Related]  

  • 80. Antineoplastic activity of derivatives of phosphoric acid.
    Serebryanyi AM; Zoz NN; Semenova NA; Morozova IS; Kolotenkov PV; Babaev MS
    Biol Bull Acad Sci USSR; 1979; 6(4):497-8. PubMed ID: 549685
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.